 2 RCTs (740 patients) (RR, 0.51; 95% CI, 0.28 to 0.91;
I2 ¼ 0.00%)

B (rated down owing to risk of
bias)

Total AEs

2 RCTs (710 patients)
One observational study
(60 patients)

C (rated down owing to risk of
bias and inconsistency)
C (rated down owing to risk of
bias and imprecision owing
to small sample size)

EVLA vs CAC
(RR, 1.65; 95% CI, 1.16 to 2.35; I2 ¼ 72.5%)
RFA vs NBCA
(RR,1.63; 95% CI, 1.13 to 2.33)

B (rated down owing to risk of
bias)

Key Question 4. Incompetent perforators ablation vs no ablation
Anatomic closure at
1 year

2 RCT (141 patients)

SFL/S with SEPS and concomitant
phlebectomy vs SFL/S with
concomitant phlebectomy
(RR, 3.13; 95% CI, 1.57 to 6.23)
IPV EVLA vs GSV EVLA
(RR, 1.02; 95% CI, 0.63 to 1.64)

C (rated down owing to risk of
bias and imprecision)

CAC, Cyanoacrylate closure; CI, conﬁdence interval; DUS, duplex ultrasound; EVLA, endovenous laser ablation; GSV, great saphenous vein; HHD, handheld Doppler; HL/S, high ligation and stripping; IPV, incompetent perforator vein; NBCA, n-butyl cyanoacrylate; RFA, radiofrequency ablation; RCT,
randomized controlled trial; RR, relative risk/rate ratio for adverse events; SEPS, subfascial endoscopic perforator surgery; SFJ, saphenofemoral
junction; SFL/S, saphenofemoral ligation and stripping; SMD, standardized mean difference; UGFS, ultrasound